Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 375.50
+3.50 (0.94%)
Feb 27, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 174.85 billion as of February 27, 2026. Its market cap has decreased by -7.20% in one year.
Market Cap
174.85B
Enterprise Value
195.96B
Revenue
30.94B
Ranking
n/a
PE Ratio
26.29
Stock Price
375.50
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 174.85B, an increase of 1,135.84%. That is a compound annual growth rate of 10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 174.85B | -7.92% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 388.50B |
| Danske Bank | 268.55B |
| A.P. Møller - Mærsk | 226.71B |
| Ørsted | 198.16B |
| Vestas Wind Systems | 160.58B |
| Carlsberg | 130.91B |
| Genmab | 113.82B |
| Coloplast | 109.88B |